Physician

Matthew M Akers, M.D.

According to 2025 Medicare claims, Matthew Akers, M.D. (NPI: 1649271222) practices plastic and reconstructive surgery in the Lima, OH market, with the plurality of this provider's patient population coming from Allen, OH. This provider's primary affiliated billing organization is RENAISSANCE RECONSTRUCTIVE & AESTHETIC SURGERY INC (NPI: 1659616852; TIN: 311671524) and primary practice location at 45801-4667.

Akers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 519 traditional Medicare patients, billed 1,874 HCPCS/CPT codes, and received $434,279 in Medicare payments. The top billing code was 15260 (Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less). Part D data shows 697 prescription claims across 530 beneficiaries totaling $5,039 in drug costs, led by Cefadroxil (Cefadroxil). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have declined steadily, from $12,776 to $5,039. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$301K$601K2015 Medicare payment: $296,142 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $420,895 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $474,581 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $514,689 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $496,590 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $435,453 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $587,849 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $547,971 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $601,490 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $434,279 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155091,655$296,142
20165842,167$420,895
20176382,637$474,581
20186282,542$514,689
20196122,508$496,590
20205612,591$435,453
20216252,784$587,849
20225912,562$547,971
20236282,644$601,490
20245191,874$434,279

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$6.8K$14K2015 Drug cost: $12,776 (USD; Tot_Drug_Cst)2016 Drug cost: $12,444 (USD; Tot_Drug_Cst)2017 Drug cost: $13,559 (USD; Tot_Drug_Cst)2018 Drug cost: $13,532 (USD; Tot_Drug_Cst)2019 Drug cost: $12,294 (USD; Tot_Drug_Cst)2020 Drug cost: $10,530 (USD; Tot_Drug_Cst)2021 Drug cost: $12,003 (USD; Tot_Drug_Cst)2022 Drug cost: $11,061 (USD; Tot_Drug_Cst)2023 Drug cost: $9,689 (USD; Tot_Drug_Cst)2024 Drug cost: $5,039 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015390604$12,776
2016434731$12,444
2017523897$13,559
2018481774$13,532
2019503749$12,294
2020504813$10,530
2021625911$12,003
2022595855$11,061
2023641845$9,689
2024530697$5,039

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
15260Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less8991$565
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks275327$420
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks8095$275
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more209209$67
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more170202$53

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CefadroxilCefadroxil4813,403$2,911
Doxycycline HyclateDoxycycline Hyclate126882$918
AzithromycinAzithromycin1480$87
Ciprofloxacin HclCiprofloxacin Hcl11102$70
Chlorhexidine GluconateChlorhexidine Gluconate12189$65

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Matthew M. Akers, M.D.?

Tedicare shows public-source Medicare data for Matthew M. Akers, M.D. (NPI 1649271222), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew M. Akers, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew M. Akers, M.D.?

Matthew M. Akers, M.D. is linked to RENAISSANCE RECONSTRUCTIVE & AESTHETIC SURGERY INC (billing NPI 1659616852) in the available physician profile data.

Does Matthew M. Akers, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.